95 related articles for article (PubMed ID: 9083148)
1. Expression of bcl-2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis.
Ohbu M; Saegusa M; Kobayashi N; Tsukamoto H; Mieno H; Kakita A; Okayasu I
Cancer; 1997 Apr; 79(7):1287-93. PubMed ID: 9083148
[TBL] [Abstract][Full Text] [Related]
2. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
[TBL] [Abstract][Full Text] [Related]
3. Expressions of p53, VEGF C, p21: could they be used in preoperative evaluation of lymph node metastasis of esophageal squamous cell carcinoma?
Han U; Can OI; Han S; Kayhan B; Onal BU
Dis Esophagus; 2007; 20(5):379-85. PubMed ID: 17760650
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma.
Szumilo J; Chibowski D; D browski A
Dis Esophagus; 2000; 13(3):191-7. PubMed ID: 11206631
[TBL] [Abstract][Full Text] [Related]
5. Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma.
Mukherjee T; Kumar A; Mathur M; Chattopadhyay TK; Ralhan R
J Cancer Res Clin Oncol; 2003 Jul; 129(7):430-6. PubMed ID: 12851814
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of EGFR family expression in lymph node-negative esophageal squamous cell carcinoma patients.
Yu W; Yang X; Chu L; Zhao K; Chen H; Xiang J; Zhang Y; Li H; Zhao W; Sun M; Wei Q; Fu X; Xie C; Zhu Z
Pathol Res Pract; 2018 Jul; 214(7):1017-1023. PubMed ID: 29729836
[TBL] [Abstract][Full Text] [Related]
7. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
9. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
[TBL] [Abstract][Full Text] [Related]
10. Regulation of apoptosis in squamous cell carcinoma of the vulva.
Hantschmann P; Kürzl R
J Reprod Med; 2000 Aug; 45(8):633-42. PubMed ID: 10986681
[TBL] [Abstract][Full Text] [Related]
11. Expression of Bax, a pro-apoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Sarbia M; Bittinger F; Grabellus F; Verreet P; Dutkowski P; Willers R; Gabbert HE
Int J Cancer; 1997 Nov; 73(4):508-13. PubMed ID: 9389564
[TBL] [Abstract][Full Text] [Related]
12. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
Sano M; Aoyagi K; Takahashi H; Kawamura T; Mabuchi T; Igaki H; Tachimori Y; Kato H; Ochiai A; Honda H; Nimura Y; Nagino M; Yoshida T; Sasaki H
Int J Oncol; 2010 Feb; 36(2):321-30. PubMed ID: 20043065
[TBL] [Abstract][Full Text] [Related]
15. Expression of heat shock protein 70 in grossly resected esophageal squamous cell carcinoma.
Noguchi T; Takeno S; Shibata T; Uchida Y; Yokoyama S; Müller W
Ann Thorac Surg; 2002 Jul; 74(1):222-6. PubMed ID: 12118763
[TBL] [Abstract][Full Text] [Related]
16. Esophageal squamous cell carcinomas and expression of p53, Bcl-2, and Bcl-X(L).
Vlachos K; Siafakas N; Karameris A; Theodoropoulos G; Parassi E; Peros G; Papadopoulos J; Hakim N
Int Surg; 2008; 93(2):63-71. PubMed ID: 18998283
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus.
Sarbia M; Bittinger F; Porschen R; Verreet P; Dutkowski P; Willers R; Gabbert HE
Int J Cancer; 1996 Aug; 69(4):324-8. PubMed ID: 8797876
[TBL] [Abstract][Full Text] [Related]
18. [Expression of activin A in tissue and serum of patients with esophageal squamous cell carcinoma and its clinical significance].
Liu SG; Li HC; Zhao BS; Cao F
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):843-7. PubMed ID: 24447483
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
20. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
